MD · MBA
Founder & CEO, Sequencing.com
Founder of Sequencing and author of Outsmart Your Genes. An early voice in direct-to-consumer genetic testing.
Brandon Colby is a physician-expert in the fields of Genetic Analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University`s Graduate School of Business, and a BA with Honors in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Dr. Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore congenital membranous nephropathy, a kidney disorder in newborns, and how genetic testing aids in early diagnosis, treatment, and family planning.
Explore how genetic testing revolutionizes congenital myasthenic syndrome diagnosis, offering precision, tailored treatments, and informed family planning insights.
Unlock better diagnosis and treatment for Congenital Nonbullous Ichthyosiform Erythroderma through genetic testing. Explore personalized care and family planning options.
Meta Description: Explore how genetic testing aids in diagnosing congenital omphalocele, identifies genetic syndromes, and guides family planning for improved outcomes.
Explore how genetic testing can revolutionize CSWS management, providing insights for diagnosis, personalized treatment, and informed family planning decisions.
Unravel the genetic basis of CPVSF1B. Understand diagnosis, benefits of early detection, and family planning with MYH3 gene insights in this rare disorder.
Explore how genetic testing revolutionizes craniopharyngioma treatment by enabling early detection, personalized therapies, and improved patient outcomes.
Unlock insights into Cushing syndrome's genetics with testing. Identify mutations, enable personalized treatments, and explore ARMC5's role in managing adrenal hyperplasias.